Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_B6,10 | Lung | Primary cancer | 3,533 | Stromal | 45.4% | 0.90 | 0.32 |
| NSCLC_38242124__IMC__87_B6,11 | Lung | Primary cancer | 3,555 | Tumor/Malignant | 51.0% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__87_B6,12 | Lung | Primary cancer | 3,804 | Tumor/Malignant | 31.1% | 0.94 | 0.23 |
| NSCLC_38242124__IMC__87_B6,13 | Lung | Primary cancer | 4,404 | Immune | 38.0% | 0.95 | 0.20 |
| NSCLC_38242124__IMC__87_B6,14 | Lung | Primary cancer | 2,764 | Tumor/Malignant | 59.6% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__87_B6,15 | Lung | Primary cancer | 3,800 | Stromal | 32.6% | 0.63 | 0.76 |
| NSCLC_38242124__IMC__87_B6,16 | Lung | Primary cancer | 3,370 | Tumor/Malignant | 29.4% | 0.89 | 0.29 |
| NSCLC_38242124__IMC__87_B6,17 | Lung | Primary cancer | 3,543 | Tumor/Malignant | 62.3% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__87_B6,2 | Lung | Primary cancer | 1,932 | Immune | 24.7% | 0.43 | 0.97 |
| NSCLC_38242124__IMC__87_B6,3 | Lung | Primary cancer | 1,848 | Tumor/Malignant | 40.0% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__87_B6,4 | Lung | Primary cancer | 4,237 | Tumor/Malignant | 86.1% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__87_B6,5 | Lung | Primary cancer | 5,070 | Tumor/Malignant | 28.3% | 0.85 | 0.41 |
| NSCLC_38242124__IMC__87_B6,6 | Lung | Primary cancer | 2,534 | Tumor/Malignant | 59.7% | 0.95 | 0.21 |
| NSCLC_38242124__IMC__87_B6,7 | Lung | Primary cancer | 4,179 | Stromal | 61.7% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__87_B6,8 | Lung | Primary cancer | 3,449 | Tumor/Malignant | 53.6% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__87_B6,9 | Lung | Primary cancer | 3,163 | Immune | 26.8% | 0.41 | 0.93 |
| NSCLC_38242124__IMC__87_B7,1 | Lung | Primary cancer | 3,258 | Tumor/Malignant | 45.7% | 0.96 | 0.11 |
| NSCLC_38242124__IMC__87_B7,10 | Lung | Primary cancer | 5,361 | Tumor/Malignant | 84.0% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__87_B7,11 | Lung | Primary cancer | 3,962 | Tumor/Malignant | 78.6% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__87_B7,12 | Lung | Primary cancer | 1,054 | Stromal | 39.4% | 0.98 | 0.06 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_B6,10 | Lung | Primary cancer | 3,533 | Stromal | 40.7% | 0.90 | 0.28 |
| NSCLC_38242124__IMC__87_B6,11 | Lung | Primary cancer | 3,555 | Tumor/Malignant | 50.4% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__87_B6,12 | Lung | Primary cancer | 3,804 | Tumor/Malignant | 31.3% | 0.94 | 0.24 |
| NSCLC_38242124__IMC__87_B6,13 | Lung | Primary cancer | 4,404 | Lymphoid | 29.4% | 0.90 | 0.34 |
| NSCLC_38242124__IMC__87_B6,14 | Lung | Primary cancer | 2,764 | Tumor/Malignant | 41.3% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__87_B6,15 | Lung | Primary cancer | 3,800 | Stromal | 23.0% | 0.37 | 1.06 |
| NSCLC_38242124__IMC__87_B6,16 | Lung | Primary cancer | 3,370 | Tumor/Malignant | 23.9% | 0.93 | 0.19 |
| NSCLC_38242124__IMC__87_B6,17 | Lung | Primary cancer | 3,543 | Tumor/Malignant | 49.8% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__87_B6,2 | Lung | Primary cancer | 1,932 | Stromal | 23.9% | 0.51 | 0.92 |
| NSCLC_38242124__IMC__87_B6,3 | Lung | Primary cancer | 1,848 | Tumor/Malignant | 42.2% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__87_B6,4 | Lung | Primary cancer | 4,237 | Tumor/Malignant | 90.1% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__87_B6,5 | Lung | Primary cancer | 5,070 | Myeloid | 21.5% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__87_B6,6 | Lung | Primary cancer | 2,534 | Tumor/Malignant | 46.5% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__87_B6,7 | Lung | Primary cancer | 4,179 | Stromal | 40.1% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__87_B6,8 | Lung | Primary cancer | 3,449 | Tumor/Malignant | 38.2% | 0.99 | 0.07 |
| NSCLC_38242124__IMC__87_B6,9 | Lung | Primary cancer | 3,163 | Stromal | 23.0% | 0.35 | 1.06 |
| NSCLC_38242124__IMC__87_B7,1 | Lung | Primary cancer | 3,258 | Tumor/Malignant | 44.5% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__87_B7,10 | Lung | Primary cancer | 5,361 | Tumor/Malignant | 77.6% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__87_B7,11 | Lung | Primary cancer | 3,962 | Tumor/Malignant | 78.3% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__87_B7,12 | Lung | Primary cancer | 1,054 | Stromal | 52.6% | 0.95 | 0.14 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_B6,10 | Lung | Primary cancer | 3,533 | Fibroblast | 43.8% | 0.89 | 0.33 |
| NSCLC_38242124__IMC__87_B6,11 | Lung | Primary cancer | 3,555 | Tumor/Malignant cell | 52.6% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__87_B6,12 | Lung | Primary cancer | 3,804 | Tumor/Malignant cell | 38.0% | 0.91 | 0.33 |
| NSCLC_38242124__IMC__87_B6,13 | Lung | Primary cancer | 4,404 | Tumor/Malignant cell | 31.1% | 0.82 | 0.51 |
| NSCLC_38242124__IMC__87_B6,14 | Lung | Primary cancer | 2,764 | Tumor/Malignant cell | 60.2% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__87_B6,15 | Lung | Primary cancer | 3,800 | Fibroblast | 22.1% | 0.62 | 0.86 |
| NSCLC_38242124__IMC__87_B6,16 | Lung | Primary cancer | 3,370 | Tumor/Malignant cell | 28.4% | 0.90 | 0.29 |
| NSCLC_38242124__IMC__87_B6,17 | Lung | Primary cancer | 3,543 | Tumor/Malignant cell | 49.2% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__87_B6,2 | Lung | Primary cancer | 1,932 | Fibroblast | 26.0% | 0.39 | 1.08 |
| NSCLC_38242124__IMC__87_B6,3 | Lung | Primary cancer | 1,848 | Tumor/Malignant cell | 41.2% | 0.95 | 0.17 |
| NSCLC_38242124__IMC__87_B6,4 | Lung | Primary cancer | 4,237 | Tumor/Malignant cell | 92.0% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__87_B6,5 | Lung | Primary cancer | 5,070 | Tumor/Malignant cell | 28.2% | 0.86 | 0.43 |
| NSCLC_38242124__IMC__87_B6,6 | Lung | Primary cancer | 2,534 | Tumor/Malignant cell | 60.5% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__87_B6,7 | Lung | Primary cancer | 4,179 | Fibroblast | 59.8% | 0.95 | 0.15 |
| NSCLC_38242124__IMC__87_B6,8 | Lung | Primary cancer | 3,449 | Tumor/Malignant cell | 55.5% | 0.93 | 0.20 |
| NSCLC_38242124__IMC__87_B6,9 | Lung | Primary cancer | 3,163 | T cell | 25.2% | 0.41 | 0.97 |
| NSCLC_38242124__IMC__87_B7,1 | Lung | Primary cancer | 3,258 | Tumor/Malignant cell | 45.9% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__87_B7,10 | Lung | Primary cancer | 5,361 | Tumor/Malignant cell | 83.5% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__87_B7,11 | Lung | Primary cancer | 3,962 | Tumor/Malignant cell | 77.8% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__87_B7,12 | Lung | Primary cancer | 1,054 | Fibroblast | 41.6% | 0.89 | 0.29 |